An interventional study of herbal tea intervention in Diet, Healthy, sponsored by Dr.Ruba Musharbash. Status unknown at 1 site in Jordan. Open to participants aged 19 Years to 57 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-17.
Sponsored by Dr.Ruba Musharbash · Not applicable, Interventional, and Other
investigate beneficial effect of an herbal tea prepared from carob pulp and pods (Ceratonia siliqua), anise seed (Pimpinella Anisum L), wild thyme, green tea and eucalyptus leaves with Manuka honey (natural sweetener) on lipid profile and insulin resistance, CRP (C-reactive protein), CBC (complete blood count), liver function test, kidney function tests, inflammation and anthropometric indices in adults living in Amman Jordan
This study will be carried out to examine the effect of herbal tea in recruited subjects in an intervention single-group pretest-posttest study for a period of 7 weeks. Subjects will consume twice a day for a period of 7 weeks an herbal tea of (carob, anise, wild thyme, and eucalyptus leaves) before eating. The total sample (n=30) adults aged (19-57 years) , body mass index BMI range (19-35 kg/m2)
1,960 studies on the registry are indexed under Insulin Resistance; 306 are open to participants now.
This study's enrollment of 30 is below the median of 40 across 1,536 interventional studies indexed under Insulin Resistance.
Browse Insulin Resistance studies →This is the only study on the registry with Dr.Ruba Musharbash as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
adults aged 19-57 years old living in Amman Jordan, body mass index between 19-57
Other: herbal tea intervention
herbal tea intervention for 7 weeks
Also known as: herbal tea, carob, anise, green tea, manuka honey, wild thyme, eucalyptus leaves
Questionnaire
basic demographic information
Time frame: 1-2 weeks
Homocysteine serum level
venous blood sample for 30 candidates measured by umol/L normal range \< 12 umol/L
Time frame: 7 weeks pre and post intervention
Fasting blood sugar
venous blood sample for 30 candidates measured by mg/dL normal range 70-99 mg/dL
Time frame: 7 weeks pre and post intervention
Glycosylated Haemoglobin (HBA1C) blood
venous blood sample for 30 candidates measured by percentage normal range 4.8-5.8%
Time frame: 7 weeks pre and post intervention
Cholesterol serum
venous blood sample for 30 candidates measured by mg/dL normal range \<200 mg/dL
Time frame: 7 weeks pre and post intervention
Triglyceride serum
venous blood sample for 30 candidates measured by mg/dL normal range \<150 mg/dL
Time frame: 7 weeks pre and post intervention
HDL cholesterol(High density lipoprotein) serum
venous blood sample for 30 candidates measured by mg/dL normal range \>60mg/dL
Time frame: 7 weeks pre and post intervention
Cholesterol/HDL Ratio
venous blood sample for 30 candidates normal range \<4.0
Time frame: 7 weeks pre and post intervention
LDL Cholesterol (low density lipoprotein) serum
venous blood sample for 30 candidates measured by mg/dL normal range \<100mg/dL
Time frame: 7 weeks pre and post intervention
Protein serum
venous blood sample for 30 candidates measured by g/dL normal range 6.0-8.0g/dL
Time frame: 7 weeks pre and post intervention
C-Reactive Protein high sensitivity serum
venous blood sample for 30 candidates measured by mg/dL , low risk of CVD \<1.0 mg/dL
Time frame: 7 weeks pre and post intervention
Insulin serum
venous blood sample for 30 candidates measured by uU/ml normal range 2.6-24.9
Time frame: 7 weeks pre and post intervention
Cortisol Total (AM) serum
venous blood sample for 30 candidates measured by ug/dL normal range 6.02-18.4
Time frame: 7 weeks pre and post intervention
Tumor Necrosis Factor
venous blood sample for 30 candidates measured by pg/mL normal range upto 8.1
Time frame: 7 weeks pre and post intervention
8-OH-2 Desoxyyguanosine urine
Urine sample measured by micromol/mol normal range 0.1-2.4
Time frame: 7 weeks pre and post intervention
interleukin 1 Beta
venous blood sample for 30 candidates measured by pg/ml normal range upto 5 pg/ml
Time frame: 7 weeks pre and post intervention
weight
measured on inbody 770 measured by kg
Time frame: 7 weeks pre and post intervention
Height
measured by cm
Time frame: pre intervention
gastrointestinal symptoms questionnaire
measure severity of GI symptoms including bloating , flatulence, gastrointestinal pain and loss of appetite, measure the occurrence of these symptoms and reduction in mean severity symptoms after herbal intervention
Time frame: 7 weeks pre and post intervention
Creatinine serum
venous blood sample for 30 candidates measured by mg/dL normal range male 0.7-1.2mg/dL females 0.5-0.9mg/dL
Time frame: 7 weeks pre and post intervention
Alanine Aminotransferase (ALT/GPT) serum
Venous blood sample for 30 candidates measured by U/L normal range Upto 41 U/L
Time frame: 7 weeks pre and post intervention
Aspartate Aminotransferase (AST/GOT) serum
Venous blood sample for 30 candidates measured by U/L normal range Upto 40 U/L
Time frame: 7 weeks pre and post intervention
Gamma-Glutamyl Transferase (GGT) serum
Venous blood sample for 30 candidates measured by U/L normal range 8-61 U/L
Time frame: 7 weeks pre and post intervention
Alkaline phosphatase serum
Venous blood sample for 30 candidates measured by U/L normal range 40-129
Time frame: 7 weeks pre and post intervention
Creatine phospho Kinase (CPK)
Venous blood sample for 30 candidates measured by U/L normal range males 20-200 U/L females 20-180 U/L
Time frame: 7 weeks pre and post intervention
Microalbuminuria spot urine
Urine sample measured by mg/L normal range \<20.0 mg/L
Time frame: 7 weeks pre and post intervention
Creatinine spot urine
Urine sample measured by mg/dL normal range males 39-259 mgd/L females 28-217mg/dL
Time frame: 7 weeks pre and post intervention
Microalbuminuria-Creatinine spot urine
Urine sample measured by by mg/g creat. normal range \< 30.0 mg/g creat.
Time frame: 7 weeks pre and post intervention
Haemoglobin
Venous blood sample for 30 candidates measured by gm/L males 140-180 gm/L females 120-160 gm/L
Time frame: 7 weeks pre and post intervention
haematocrit
Venous blood sample for 30 candidates measured by L/L males 0.42-0.54L/L females 0.37-0.47 L/L
Time frame: 7 weeks pre and post intervention
Erythrocytes
Venous blood sample for 30 candidates measured by x10\^12/L males 4.7-6.1 x10\^12/L females 4.2-5.4 x10\^12/L
Time frame: 7 weeks pre and post intervention
MCV
Venous blood sample for 30 candidates measured by FL normal range 80-96 FL
Time frame: 7 weeks pre and post intervention
MCH
Venous blood sample for 30 candidates measured by pg normal range 27-31 pg
Time frame: 7 weeks pre and post intervention
MCHC
Venous blood sample for 30 candidates measured by gm/L normal range 320-360gm/L
Time frame: 7 weeks pre and post intervention
RDW- cv
Venous blood sample for 30 candidates measured by percentage normal range 11.5-14.5%
Time frame: 7 weeks pre and post intervention
Leukocytes
Venous blood sample for 30 candidates measured by x10\^9/L normal range 4.500-10.000
Time frame: 7 weeks pre and post intervention
platelets
Venous blood sample for 30 candidates measured by x10\^9/L normal range 150-400
Time frame: 7 weeks pre and post intervention
Skeletal muscle mass
measured on inbody 770 measured by kg
Time frame: 7 weeks pre and post intervention
Body fat mass
measured on inbody 770 measured by kg
Time frame: 7 weeks pre and post intervention
Percent body fat mass
measured on inbody 770 measured by percentage
Time frame: 7 weeks pre and post intervention
free fat muscle
measured on inbody 770 measured by kg
Time frame: 7 weeks pre and post intervention
Visceral fat are
measured on inbody 770 measured by cm2
Time frame: 7 weeks pre and post intervention
total body water
measured on inbody 770 measured by L
Time frame: 7 weeks pre and post intervention
Body mass index
measured on inbody 770 measured by kg/m2
Time frame: 7 weeks pre and post intervention
Basal metabolic rate
measured on inbody 770 measured by kcal
Time frame: 7 weeks pre and post intervention
waist circumference
measured by cm measures using measuring tape
Time frame: 7 weeks pre and post intervention
Hip circumference
measured by cm measures using measuring tape
Time frame: 7 weeks pre and post intervention
Waist/hip ratio
measured using equation waist/hip
Time frame: 7 weeks pre and post intervention
Waist/height ratio
measured using equation waist/height
Time frame: 7 weeks pre and post intervention
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.